Discontinuation of disease modifying therapies is associated with disability progression regardless of prior stable disease and age. uri icon

authors

  • Dejan Jakimovski MD, PhD
  • Perel, Allan
  • Zivadinov, Robert
  • Weinstock-Guttman, Bianca
  • Kavak, Katelyn S
  • Vaughn, Caila B
  • Goodman, Andrew D
  • Coyle, Patricia K
  • Krupp, Lauren
  • Gottesman, Malcolm
  • Edwards, Keith R
  • Lenihan, Michael

publication date

  • January 1, 2021